Evrysdi™ approved for the treatment of spinal muscular atrophy
PTC Therapeutics, Inc. have announced that Evrysdi™ (risdiplam) has been approved in Brazil by the National Health Surveillance Agency (ANVISA) for the treatment of...
New transatlantic cancer research partnership
The two largest funders of cancer research in the world are set to make radical progress against cancer with a new scientific cancer research...
Creativity not commercialism is needed in healthcare
Phil Blackmore discusses why creativity is more important than commercialism in healthcare marketing. In recent months there’s been a lot of talk about the evolution of...
Changes to the landscape of commercial recruitment
As Covid-19 continues to shift and shape the landscape of commercial recruitment, Pf talks with Andy Anderson at Evolve about its impact going forward. How...
Why candidates need to be omnichannel ready
Judy Phillips from Chase looks at how working practices are changing and why it is important that candidates in 2020 are omnichannel ready. COVID-19 and...
Interview with Pf Awards Future Leader winner
In this interview, Pf Awards Future Leader winner, Lauren Laskier, reflects on her accolade and how the recognition has pushed her forward in her...
Has Covid-19 changed working practices in the UK for good?
Emma Clayton, Managing Director of Grey Bear Consultancy, looks at how the pandemic has changed working practices – what are the benefits and challenges...
COVID-19: changing the pharma workforce
There’s no denying the COVID-19 has changed the world, but will it have a lasting effect on the pharma workforce? Graham Hawthorn
Managing Director, CHASE It is...
The importance of security for medical device firms
With news hitting the headlines that global pharmaceutical company Pfizer Inc. has suffered a huge data breach and in light of National Cyber Security...
How sales professionals can engage with their customers during COVID-19
The impact of COVID-19 has affected how sales professionals engage with customers. What does the way forward look like? Richard Gray and Stephen Dempster...
